Post-Market Surveillance With a Novel mHealth Platform

Completed

Conditions studied: Gastrectomy, Atrial Fibrillation

In brief

This is a study to pilot the feasibility of using a novel patient-led, smartphone-based mobile health platform (Hugo) for real-world surveillance of outcomes of patients after they undergo a bariatric surgical procedure (either sleeve gastrectomy or gastric bypass) and catheter-based atrial fibrillation ablation

Key facts

Study ID

NCT03436082

Run by

Yale University

People needed

60

Starts

2018-01-26

Expected to finish

2018-12-25

Last updated by the study team

2021-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >18
• English-speaking
• Planned for either a bariatric surgical procedure (either sleeve gastrectomy or gastric bypass) or catheter-based atrial fibrillation ablation
• Participant is willing and able to read and sign consent and participate in study
• Participant has an email account and a mobile device (smartphone or tablet) able to download the necessary applications
• Participant is willing to use the mobile health platform and syncable devices (e.g. Fitbit Charge 2)
• Attending bariatric surgeon or electrophysiologist (as appropriate) concurs that patient is a candidate for enrollment

You may not qualify if…

• Healthy patients
• Patients who refuse participation

Where it is running

• Yale New Haven Hospital — New Haven, Connecticut, United States
• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.